H. J. Arnqvist

1.1k total citations
27 papers, 770 citations indexed

About

H. J. Arnqvist is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Genetics. According to data from OpenAlex, H. J. Arnqvist has authored 27 papers receiving a total of 770 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Endocrinology, Diabetes and Metabolism, 11 papers in Molecular Biology and 8 papers in Genetics. Recurrent topics in H. J. Arnqvist's work include Diabetes and associated disorders (8 papers), Metabolism, Diabetes, and Cancer (8 papers) and Diabetes Management and Research (7 papers). H. J. Arnqvist is often cited by papers focused on Diabetes and associated disorders (8 papers), Metabolism, Diabetes, and Cancer (8 papers) and Diabetes Management and Research (7 papers). H. J. Arnqvist collaborates with scholars based in Sweden, Canada and United States. H. J. Arnqvist's co-authors include H. von Schenck, Johan Permert, D. G. Joakim Larsson, L. Jorfeldt, Ingemar Ihse, Bertil Ekman, Fredrik H. Nyström, Alan Wayne Jones, Bengt Littorin and L Wibell and has published in prestigious journals such as European Heart Journal, Diabetologia and Clinical Chemistry.

In The Last Decade

H. J. Arnqvist

27 papers receiving 735 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H. J. Arnqvist Sweden 13 370 284 269 199 149 27 770
Nobuaki Kuzuya Japan 16 389 1.1× 134 0.5× 162 0.6× 196 1.0× 96 0.6× 31 762
Margaret Warren-Perry United Kingdom 15 221 0.6× 315 1.1× 210 0.8× 238 1.2× 84 0.6× 20 845
Abraham Borkowski Belgium 14 264 0.7× 174 0.6× 120 0.4× 81 0.4× 178 1.2× 33 845
Jean-Marie Saudubray France 14 333 0.9× 383 1.3× 210 0.8× 111 0.6× 42 0.3× 15 952
Hélène Gibelin France 16 271 0.7× 251 0.9× 389 1.4× 52 0.3× 121 0.8× 32 837
Andrew K. Gormley United States 9 173 0.5× 260 0.9× 333 1.2× 162 0.8× 75 0.5× 13 755
Pratik Shah United Kingdom 19 704 1.9× 237 0.8× 395 1.5× 216 1.1× 94 0.6× 67 1.1k
Leann Olansky United States 16 408 1.1× 305 1.1× 185 0.7× 56 0.3× 82 0.6× 29 726
R Mahler United Kingdom 11 222 0.6× 213 0.8× 198 0.7× 109 0.5× 45 0.3× 38 799
Yuichi Takashi Japan 18 217 0.6× 313 1.1× 115 0.4× 154 0.8× 157 1.1× 51 890

Countries citing papers authored by H. J. Arnqvist

Since Specialization
Citations

This map shows the geographic impact of H. J. Arnqvist's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. J. Arnqvist with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. J. Arnqvist more than expected).

Fields of papers citing papers by H. J. Arnqvist

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. J. Arnqvist. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. J. Arnqvist. The network helps show where H. J. Arnqvist may publish in the future.

Co-authorship network of co-authors of H. J. Arnqvist

This figure shows the co-authorship network connecting the top 25 collaborators of H. J. Arnqvist. A scholar is included among the top collaborators of H. J. Arnqvist based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. J. Arnqvist. H. J. Arnqvist is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Arnqvist, H. J., et al.. (2010). OR9,53 Higher circulating IGF-I bioactivity and total IGF-I with intraperitoneal insulin delivery than with CSII in type 1 diabetes. Growth Hormone & IGF Research. 20. S24–S25. 2 indexed citations
2.
Arnqvist, H. J., et al.. (2008). Mitogenic Effect of the Insulin Analogue Glargine in Malignant Cells in Comparison with Insulin and IGF-I. Hormone and Metabolic Research. 40(6). 369–374. 48 indexed citations
3.
Bakhtadze, E., Gunnar Stenström, Per Fernlund, et al.. (2006). HLA-DQB1 genotypes, islet antibodies and beta cell function in the classification of recent-onset diabetes among young adults in the nationwide Diabetes Incidence Study in Sweden. Diabetologia. 49(8). 1785–1794. 11 indexed citations
4.
Arnqvist, H. J., et al.. (2005). Expression and function of receptors for insulin-like growth factor-I and insulin in human coronary artery smooth muscle cells. Diabetologia. 48(10). 2155–2161. 24 indexed citations
5.
Bolinder, Jan, Per Fernlund, H. J. Arnqvist, et al.. (2005). Hyperproinsulinemia segregates young adult patients with newly diagnosed autoimmune (type 1) and non‐autoimmune (type 2) diabetes. Scandinavian Journal of Clinical and Laboratory Investigation. 65(7). 585–594. 6 indexed citations
6.
Schölin, Anna, Carina Törn, L. Nyström, et al.. (2004). Normal weight promotes remission and low number of islet antibodies prolong the duration of remission in Type 1 diabetes. Diabetic Medicine. 21(5). 447–455. 32 indexed citations
7.
Arnqvist, H. J., et al.. (2003). IGF-I but not insulin inhibits apoptosis at a low concentration in vascular smooth muscle cells. Journal of Endocrinology. 179(2). 267–274. 10 indexed citations
8.
Borg, Håkan, H. J. Arnqvist, Erik Björk, et al.. (2002). Islet antibodies at diagnosis versus beta-cell function eight years later in young adult patients with diabetes.. Diabetologia. 45. 476. 2 indexed citations
9.
Ekman, Bertil, et al.. (2002). A dose titration model for recombinant GH substitution aiming at normal plasma concentrations of IGF-I in hypopituitary adults. European Journal of Endocrinology. 49–57. 8 indexed citations
10.
Ekman, Bertil, Fredrik H. Nyström, & H. J. Arnqvist. (2000). Circulating IGF-I concentrations are low and not correlated to glycaemic control in adults with type 1 diabetes. European Journal of Endocrinology. 143(4). 505–510. 40 indexed citations
11.
Andersson, Per, Thomas Gustafsson, & H. J. Arnqvist. (1999). Insulin-like growth factor binding proteins-2 to -6 are expressed by human vascular smooth muscle cells. Journal of Endocrinology. 163(2). 281–288. 11 indexed citations
12.
Gustafsson, Thomas, Patiyan Andersson, & H. J. Arnqvist. (1999). Different inhibitory actions of IGFBP-1, -2 and -4 on IGF-I effects in vascular smooth muscle cells. Journal of Endocrinology. 161(2). 245–253. 21 indexed citations
13.
Bojestig, Mats, et al.. (1998). Unchanged incidence of severe retinopathy in a population of Type 1 diabetic patients with marked reduction of nephropathy. Diabetic Medicine. 15(10). 863–869. 17 indexed citations
14.
Arnqvist, H. J., et al.. (1997). [Standards for long-term measures of blood sugar are established].. PubMed. 94(50). 4789–90. 28 indexed citations
15.
Östman, Jan, Åke Lernmark, Mona Landin‐Olsson, et al.. (1996). Autoimmune (Type 1) Diabetes in Young Adults in Sweden. Hormone and Metabolic Research. 28(7). 348–350. 11 indexed citations
16.
Arnqvist, H. J., et al.. (1994). Nutritional assessment and muscle energy metabolism in severe chronic congestive heart failure—effects of long-term dietary supplementation. European Heart Journal. 15(12). 1641–1650. 65 indexed citations
17.
Jones, Alan Wayne, et al.. (1993). Concentrations of Acetone in Venous Blood Samples from Drunk Drivers, Type-I Diabetic Outpatients, and Healthy Blood Donors. Journal of Analytical Toxicology. 17(3). 182–185. 46 indexed citations
18.
Jorfeldt, L., et al.. (1992). Tumor removal improved glucose metabolism in humans. Clinical Nutrition. 11. 17–17. 1 indexed citations
19.
Jorfeldt, L., et al.. (1991). Pre- and postprandial hyperinsulinemia during insulin pump treatment; role of the subcutaneous bolus and basal infusion.. PubMed. 16(2). 55–61. 4 indexed citations
20.
Toss, Göran, et al.. (1989). Familial hypocalciuric hypercalcaemia: a study of four kindreds. Journal of Internal Medicine. 225(3). 201–206. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nobuaki Kuzuya Breakdown of academic impact, for papers by Margaret Warren-Perry Breakdown of academic impact, for papers by Abraham Borkowski Breakdown of academic impact, for papers by Jean-Marie Saudubray Breakdown of academic impact, for papers by Hélène Gibelin Breakdown of academic impact, for papers by Andrew K. Gormley Breakdown of academic impact, for papers by Pratik Shah Breakdown of academic impact, for papers by Leann Olansky Breakdown of academic impact, for papers by R Mahler Breakdown of academic impact, for papers by Yuichi Takashi
Rankless by CCL
2026